Vanguard Group Inc Applied Molecular Transport Inc. Transaction History

Vanguard Group Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$0.16 - $0.34 $77,356 - $164,381	-483,475 Reduced 35.82%	866,392 $138,000
Q2 2023 Aug 14, 2023	SELL	$0.24 - $0.37 $306 - $472	-1,276 Reduced 0.09%	1,349,867 $350,000
Q4 2022 Feb 10, 2023	BUY	$0.35 - $1.26 $129 - $464	369 Added 0.03%	1,351,143 $567,000
Q3 2022 Nov 14, 2022	BUY	$1.12 - $3.12 $442,624 - $1.23 Million	395,200 Added 41.36%	1,350,774 $1.31 Million
Q2 2022 Aug 12, 2022	BUY	$2.76 - $7.65 $67,539 - $187,203	24,471 Added 2.63%	955,574 $2.78 Million

Q1 2022 May 13, 2022	SELL	$5.63 - $13.88 $570,392 - $1.41 Million	-101,313 Reduced 9.81%	931,103 $7 Million
Q4 2021 Feb 14, 2022	SELL	$13.23 - $26.05 $35,668 - $70,230	-2,696 Reduced 0.26%	1,032,416 $14.4 Million
Q3 2021 Nov 12, 2021	SELL	$25.87 - $46.61 $270,962 - $488,193	-10,474 Reduced 1.0%	1,035,112 $26.8 Million
Q2 2021 Aug 13, 2021	BUY	$39.76 - $64.31 $41.6 Million - $67.2 Million	1,045,586 New	1,045,586 $47.8 Million

9.42K

Ticker AMTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,900,600
Description
Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the design and development of a pipeline of oral and respiratory biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. The company's lead product candidate is AMT-101, a gastrointestinal (GI) selective oral fusion of r...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.